Citation: | Xiaoming OUYANG, Cheng ZHI, Yun ZHOU, Degui LIAO, Miaoling LAI. Effects of astragalus injection on the expression of β-Catenin and E-cadherin in human endometrial carcinoma cells[J]. Journal of Molecular Imaging, 2016, 39(3): 292-296. doi: 10.3969/j.issn.1674-4500.2016.03.28 |
[1] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
|
[2] |
张乃怿, 吴成, 廖秦平. 子宫内膜癌的现状和筛查[J]. 中华临床医师杂志: 电子版, 2011, 5(3): 804-9.
|
[3] |
陈国辉, 黄文风. 黄芪的化学成分及药理作用研究进展[J]. 中国新药杂志, 2008, 17(1): 1482-5.
|
[4] |
许良中, 杨文涛. 免疫组织化学反应结果的判断标准[J]. 中国癌症杂志, 1996, 6(4): 229-31.
|
[5] |
陈书磊, 高萍, 王涛. 黄芪抗肿瘤有效成分及其作用机制研究进展 [J]. 中国中医药现代远程教育, 2015, 13(5): 151-2.
|
[6] |
丁繁, 王小虎. 中药黄芪抗肿瘤研究进展[J]. 肿瘤学杂志, 2013, 19 (1): 64-8.
|
[7] |
Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification,and targeted therapies[J]. Cancer Control, 2009, 16 (1): 8-13.
|
[8] |
Zhou K, Wang GT, Wang YR, et al. The potential involvement of e-cadherin and beta-catenins in meningioma[J]. PLoS One, 2010, 5 (6): 1-6.
|
[9] |
卞奕丁, 万小平. WNT信号通路与子宫内膜癌研究进展[J]. 现代妇产科进展, 2015, 24(11): 868-9.
|
[10] |
Barher N. The canonical Wnt/catenin signaling pathway[J]. Methods Mol Biol, 2008, 468(4): 5-15.
|
[11] |
任世文, 李洪安, 李霞, 等. β-catenin和E-cadherin在子宫内膜癌中的表达和意义[J]. 石河子大学学报: 自然科学版, 2011, 29(4): 471-4.
|
[12] |
Scholten AN, Aliredjo R, Creutzberg CL, et al. Combined Ecadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma [J]. Inter J GynecCancer, 2006, 16(3): 1379-85.
|